Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease

NCT ID: NCT02301663

Last Updated: 2023-09-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Microvascular coronary dysfunction (MCD) (abnormities in small blood vessels/arteries in heart) with symptoms of persistent chest pain, primarily impacts women. There are an estimated 2-3 million women in the US with MCD and about 100,000 new cases annually. Recent data from our research group suggests that coronary microvascular disease impairs the way the heart relaxes. This pilot study will attempt to exacerbate this phenotype in an effort to better understand the pathophysiology of the disease. The investigators will recruit 30 volunteers total (10 healthy calibration subjects, 10 women with microvascular disease, and 10 age-match women for the group with microvascular disease). Subjects will undergo a series of "stress" maneuvers in conjunction with advanced cardiac magnetic resonance imaging.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Microvascular Coronary Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women w/microvascular disease

10 women with microvascular disease

Group Type EXPERIMENTAL

Handgrip

Intervention Type OTHER

Subjects will be asked to squeeze and handgrip dynamometer to increase cardiac metabolic demand

Altitude simulation

Intervention Type OTHER

Subjects will breathe a lower concentration of oxygen to simulate the effects of altitude.

Leg exercise

Intervention Type OTHER

Subjects will perform leg exercise to increase metabolic demand.

Normal controls

10 age-matched women with no evidence of microvascular disease

Group Type EXPERIMENTAL

Handgrip

Intervention Type OTHER

Subjects will be asked to squeeze and handgrip dynamometer to increase cardiac metabolic demand

Altitude simulation

Intervention Type OTHER

Subjects will breathe a lower concentration of oxygen to simulate the effects of altitude.

Leg exercise

Intervention Type OTHER

Subjects will perform leg exercise to increase metabolic demand.

calibration

10 healthy individuals who will help to synchronize our imaging and stress testing maneuvers.

Group Type EXPERIMENTAL

Handgrip

Intervention Type OTHER

Subjects will be asked to squeeze and handgrip dynamometer to increase cardiac metabolic demand

Altitude simulation

Intervention Type OTHER

Subjects will breathe a lower concentration of oxygen to simulate the effects of altitude.

Leg exercise

Intervention Type OTHER

Subjects will perform leg exercise to increase metabolic demand.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Handgrip

Subjects will be asked to squeeze and handgrip dynamometer to increase cardiac metabolic demand

Intervention Type OTHER

Altitude simulation

Subjects will breathe a lower concentration of oxygen to simulate the effects of altitude.

Intervention Type OTHER

Leg exercise

Subjects will perform leg exercise to increase metabolic demand.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Fully understanding and willing to undergo study procedures
2. Male or Female greater than or equal to 18 years of age
3. Understanding and willing to sign consent form.

Exclusion Criteria

1. History of cardiovascular, pulmonary, or neurological disease
2. Hypertension (sitting blood pressure \>140/90 mmHg, with measurements recorded on at least 2 occasions)
3. Diabetes
4. Unable to give informed consent;
5. Contra-indication to CMRI testing, including claustrophobia and metallic implants
6. Adherence or retention issues;
7. Women who are pregnant.
8. Allergy to animal dander.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cedars-Sinai Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Noel Bairey Merz

Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael Nelson, PhD

Role: PRINCIPAL_INVESTIGATOR

Cedars-Sinai Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cedars-Sinai Medical Center

Los Angeles, California, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Barbra Streisand Women's Heart Center

Role: CONTACT

310-423-9666

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nicole Tovar

Role: primary

310-248-6960

BS WHC, MS

Role: backup

310-423-9666

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Diastolic stress testing

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Low Risk Acute Coronary Syndrome
NCT01703156 COMPLETED NA
Both Exercise and Adenosine Stress Testing
NCT00200629 TERMINATED PHASE4